Floatz logo

Anti-Thymoglobulin, Rabbit

Adult Acute Megakaryoblastic Leukemia

National Cancer Institute (NCI)Phase 2Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Adult Acute Megakaryoblastic Leukemia cohort.

Asset / SponsorPhaseRating
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)-
National Cancer Institute (NCI)
Phase 3BB
Azacitidine
National Cancer Institute (NCI)
Phase 2B
Busulphan
National Cancer Institute (NCI)
Phase 2B
METHOTREXATE
National Cancer Institute (NCI)
Phase 2B
Cytosin-Arabinosid
National Cancer Institute (NCI)
Phase 2B

View all 16 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
72 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →